The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide.

By P. Nordmann, L. Poirel. Clinical Microbiology and Infection, 2014

653 citations recorded by the source corpus.

Subfields: Applied Microbiology and Biotechnology, Endocrinology, Molecular Medicine

View Paper: https://www.semanticscholar.org/paper/297c028b853050f30e7325c6814ef11a0079204f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Applied Microbiology and Biotechnology

1. J. Pitout
2. L. Poirel
3. P. Nordmann

In Endocrinology

1. P. Nordmann
2. J. Pitout
3. L. Poirel
4. Amy Mathers
5. G. Peirano
6. Jung Hun Lee
7. Chang-Ro Lee
8. B. Jeong

In Molecular Medicine

1. L. Poirel
2. P. Nordmann
3. J. Pitout
4. Amy Mathers
5. G. Peirano
6. Jung Hun Lee
7. Chang-Ro Lee
8. B. Jeong

Citations in the corpus

• Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance (2015, background): “pneumoniae isolates with carbapenemases requires additional permeability deficiencies, regardless of the type of carbapenemase produced (24).”
• Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods (2016, background): “Turkey may be one of the main reservoirs of OXA-48-producing K. pneumoniae (Nordmann and Poirel, 2014).”
• The Role of Epidemic Resistance Plasmids and International High-Risk Clones in the Spread of Multidrug-Resistant Enterobacteriaceae (2015, background): “The most common global type of ESBL is the CTX-M -lactamases, while the NDM, OXA-48, and KPC -lactamases are the most frequent carbapenemases among nosocomial and community isolates of Enterobacteriaceae (11).”
• Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance (2017, background): “These super strains may be practically resistant to all available classes of antibiotics, posing a great challenge to clinicians due to limited available treatment options (Munoz-Price et al. 2013; Nordmann and Poirel 2014), and are highlighted further in this review.”